Choose one or the other based on your objectives
Turchi R, Faraonio R, Lettieri-Barbato D, Aquilano K
Esta complicacin ha sido escasamente reflejada en la literatura, y considerando que la mesoterapia es una tcnica ampliamente utilizada, es posible que este tipo de reacciones estn siendo infradiagnosticadas
Practical take For clinicians, this reinforces a more nuanced approach: Match the drug to the patient profile Look beyond average weight loss alone Consider tolerability, adherence, comorbidities, access, and long-term strategy The obesity pipeline is getting deeperand that is good news for patients
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and GLP-1/GIP dual agonists, collectively referred to as GLP-1-based medications, have transformed the treatment landscape for obesity and cardiometabolic disease